更新された供給不足状況を示しています。
ある時点での供給不足の全体的状況は「供給関連情報」に定期的にアップします。
米国
- 2024.12.30
Generic Name Shortage Status Revision Date Created Date Hypromellose Ophthalmic Solution Current Shortages 29-Dec-24 8-Jun-18 Oxycodone Hydrochloride and Acetaminophen Tablets Current Shortages 29-Dec-24 19-Jul-23 Oxycodone Hydrochloride Immediate-Release Tablets Current Shortages 29-Dec-24 16-Mar-23 Lidocaine Hydrochloride Oral Topical Solution (Viscous) 2% Current Shortages 23-Dec-24 12-Apr-23 Nystatin Oral Suspension Current Shortages 23-Dec-24 21-Jun-24 - 2024.12.30
December 23, 2024
- Bezlotoxumab Injection (Discontinuation)
- 2024.12.23
- 2024.12.23
この期間中、新規（new）で公開されたDrug Shortage情報はありません。
- 2024.12.16
- 2024.12.16
December 10, 2024
- Adalimumab-Adbm Injection (Discontinuation)
December 9, 2024
- Lodoxamide Tromethamine Solution (Discontinuation)
- Tiagabine Hydrochloride Tablet (Discontinuation)
- Tigecycline Injection (Discontinuation)
- 2024.12.09
- 2024.12.09
New December 6, 2024
- Sodium Chloride 0.9% Injection (Currently In Shortage)
December 5, 2024
- Clindamycin Hydrochloride Capsule (Discontinuation)
- Cyclosporine Oral Solution (Discontinuation)
- Desmopressin Acetate Injection (Discontinuation)
- Digoxin Tablet (Discontinuation)
- Edaravone Injection (Discontinuation)
- Imatinib Mesylate Tablet (Discontinuation)
- Pantoprazole Sodium Injection (Discontinuation)
December 4, 2024
- Oxazepam Capsule (Currently In Shortage)
- Sodium Chloride 0.9% Injection (Currently In Shortage)
Updated December 6, 2024
- Amino Acid Injection (Currently In Shortage)
December 5, 2024
- Amino Acid Injection (Currently In Shortage)
- 2024.12.02
Generic Name Shortage Status Revision Date Created Date Acetylcysteine Oral and Inhalation Solution Current Shortages 27-Nov-24 8-Jun-15 Acyclovir Injection Resolved Shortages 27-Nov-24 21-Feb-24 Azathioprine Sodium Injection Current Shortages 27-Nov-24 30-Sep-24 Bumetanide Injection Current Shortages 27-Nov-24 23-Apr-21 Leucovorin Calcium Injection Current Shortages 27-Nov-24 2-Jun-15 Methylphenidate Extended Release Oral Presentations Current Shortages 27-Nov-24 15-Dec-22 Methylphenidate Immediate-Release Tablets Current Shortages 27-Nov-24 31-Jul-23 Remifentanil Injection Current Shortages 27-Nov-24 22-Jun-22 Doxorubicin Liposomal Injection Current Shortages 26-Nov-24 19-Jul-23 Mercaptopurine Tablets Current Shortages 26-Nov-24 8-Jan-24 Streptozocin Injection Current Shortages 26-Nov-24 27-Jun-22 Fluvoxamine Maleate Extended-Release Capsules Current Shortages 25-Nov-24 13-Feb-24 Potassium Iodide and Iodine (Lugol’s Solution or Strong Iodine Solution) 14 mL bottles Resolved Shortages 25-Nov-24 25-Aug-23 - 2024.12.02
この期間中、新規の不足情報はありません。
カナダ
カナダの情報はありません。
オーストラリア
- 2024.12.30
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated Choriogonadotropin alfa Injection, solution 250 microgram Current Emergency Supply Only Unexpected increase in consumer demand 24/12/2024 duloxetine hydrochloride Capsule, enteric 33.66 mg Current Unavailable Unexpected increase in consumer demand 24/12/2024 estradiol hemihydrate Drug delivery system, transdermal 1.54 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 24/12/2024 toremifene citrate Tablet, uncoated 88.5 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 24/12/2024 estradiol hemihydrate Drug delivery system, transdermal .77 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 24/12/2024 estradiol hemihydrate Drug delivery system, transdermal 3.09 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 24/12/2024 estradiol hemihydrate Drug delivery system, transdermal 2.32 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 24/12/2024 prazosin hydrochloride Tablet, uncoated 1.095 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 23/12/2024 morphine hydrochloride trihydrate Oral Liquid, solution 10 mg/mL Current Unavailable Commercial Changes / Commercial viability 23/12/2024 fentanyl Drug delivery system, transdermal 2.1 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 23/12/2024 insulin Injection, solution 100 IU/mL Current Limited Availability Transport / Logistic issues / Storage capacity issues 23/12/2024 Somatropin Injection, solution 3.33 mg/mL Resolved Available Manufacturing 23/12/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Current Limited Availability Manufacturing 23/12/2024 prilocaine hydrochloride~felypressin Injection, solution 30 mg/mL~.54 microgram/mL Current Limited Availability Manufacturing 23/12/2024 noradrenaline (norepinephrine) acid tartrate monohydrate Injection, concentrated 8 mg Resolved Available Manufacturing 23/12/2024 mesalazine Tablet, enteric coated 800 mg Anticipated Available Manufacturing 23/12/2024 olmesartan medoxomil~amlodipine besilate Tablet, film coated 40 mg~13.88 mg Resolved Available Manufacturing 23/12/2024 olmesartan medoxomil~amlodipine besilate Tablet, film coated 40 mg~6.94 mg Resolved Available Unexpected increase in consumer demand 23/12/2024 amlodipine besilate~olmesartan medoxomil Tablet, film coated 6.94 mg~20 mg Resolved Available Manufacturing 23/12/2024 levothyroxine sodium Tablet 50 microgram Current Unavailable Manufacturing 23/12/2024 ezetimibe Tablet 10 mg Resolved Available Manufacturing 23/12/2024 - 2024.12.23
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated cytarabine Injection, solution 100 mg Current Limited Availability Unexpected increase in consumer demand 20/12/2024 topiramate Tablet, film coated 25 mg Resolved Available Manufacturing 20/12/2024 topiramate Tablet, film coated 100 mg Current Unavailable Manufacturing 20/12/2024 topiramate Tablet, film coated 200 mg Current Unavailable Manufacturing 20/12/2024 heparin sodium Injection, solution 5000 IU/mL Current Limited Availability Unexpected increase in consumer demand 20/12/2024 fentanyl Drug delivery system, transdermal 16.8 mg Current Limited Availability Manufacturing 20/12/2024 olanzapine Tablet, orally disintegrating 20 mg Current Limited Availability Manufacturing 20/12/2024 levetiracetam Tablet, film coated 250 mg Resolved Available Transport / Logistic issues / Storage capacity issues 20/12/2024 doxorubicin hydrochloride Injection, concentrated 2 mg/mL Current Limited Availability Manufacturing 20/12/2024 trandolapril Capsule, hard 1 mg Current Limited Availability Manufacturing 20/12/2024 olmesartan medoxomil Tablet, film coated 40 mg Current Unavailable Manufacturing 20/12/2024 simvastatin Tablet, film coated 40 mg Resolved Available Manufacturing 20/12/2024 codeine phosphate hemihydrate~ibuprofen Tablet, film coated 12.8 mg~200 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 20/12/2024 voriconazole Injection, powder for 200 mg Current Unavailable Manufacturing 20/12/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 20/12/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Current Unavailable Manufacturing 20/12/2024 dasatinib Tablet, film coated 20 mg Anticipated Available Unexpected increase in consumer demand 20/12/2024 fenofibrate Tablet 145 mg Anticipated Available Manufacturing 20/12/2024 teriflunomide Tablet, film coated 14 mg Current Unavailable Manufacturing 20/12/2024 latanoprost~timolol maleate Eye Drops, solution .05 mg/mL~6.83 mg/mL Current Unavailable Manufacturing 20/12/2024 hydrochlorothiazide~olmesartan medoxomil~amlodipine besilate Tablet, film coated 25 mg~40 mg~6.95 mg Resolved Available Manufacturing 20/12/2024 gentamicin sulfate Injection, solution 135.6 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 20/12/2024 sodium amidotrizoate~amidotrizoate meglumine Injection, solution 40 mg/mL~260 mg/mL Current Unavailable Manufacturing 20/12/2024 fluorouracil Injection, solution 50 mg/mL Current Limited Availability Manufacturing 20/12/2024 oxycodone hydrochloride Oral Liquid, solution 1 mg/mL Resolved Available Unexpected increase in consumer demand 20/12/2024 methylphenidate hydrochloride Capsule, modified release 40 mg Resolved Available Transport / Logistic issues / Storage capacity issues 20/12/2024 methylphenidate hydrochloride Tablet, modified release 27 mg Current Limited Availability Manufacturing 19/12/2024 tazobactam sodium~piperacillin sodium Injection, powder for .54 g~4.2 g Discontinued Unavailable Unexpected increase in consumer demand 19/12/2024 fentanyl Drug delivery system, transdermal 12.6 mg Anticipated Available Manufacturing 19/12/2024 midazolam Injection, solution 5 mg Current Limited Availability Manufacturing 19/12/2024 diazepam Tablet, uncoated 2 mg Resolved Available Manufacturing 19/12/2024 azithromycin Injection, powder for 500 mg Current Unavailable Commercial Changes / Commercial viability 19/12/2024 trandolapril Capsule, hard .5 mg Current Unavailable Manufacturing 19/12/2024 trandolapril Capsule, hard 2 mg Current Unavailable Manufacturing 19/12/2024 trandolapril Capsule, hard 4 mg Current Unavailable Manufacturing 19/12/2024 quetiapine fumarate Tablet, film coated 28.78 mg Current Unavailable Manufacturing 19/12/2024 tobramycin Injection, solution 40 mg/mL Current Limited Availability Unexpected increase in consumer demand 19/12/2024 emtricitabine~tenofovir disoproxil maleate Tablet, film coated 200 mg~300 mg Current Unavailable Manufacturing 19/12/2024 cinacalcet hydrochloride Tablet 99.191 mg Current Limited Availability Manufacturing 19/12/2024 lorazepam Tablet 2.5 mg Resolved Available Manufacturing 19/12/2024 tenofovir disoproxil succinate~emtricitabine Tablet, film coated 300.6 mg~200 mg Current Unavailable Manufacturing 19/12/2024 rosuvastatin calcium Tablet, film coated 20.84 mg Current Limited Availability Manufacturing 19/12/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Current Unavailable Manufacturing 19/12/2024 cefaclor monohydrate Oral Liquid, powder for 52.45 mg/mL Resolved Available Unexpected increase in consumer demand 19/12/2024 dostarlimab Injection, intravenous infusion 500 mg/mL Resolved Available Unexpected increase in consumer demand 19/12/2024 cisplatin Injection, solution 1 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 19/12/2024 citalopram hydrobromide Tablet, film coated 24.98 mg Anticipated Available Manufacturing 19/12/2024 pravastatin sodium Tablet, uncoated 40 mg Current Unavailable Manufacturing 19/12/2024 clarithromycin Tablet, film coated 250 mg Current Unavailable Unexpected increase in consumer demand 19/12/2024 moclobemide Tablet, film coated 150 mg Resolved Available Manufacturing 19/12/2024 bupivacaine hydrochloride monohydrate Injection, solution 52.7 mg Current Unavailable Unexpected increase in consumer demand 18/12/2024 sildenafil citrate Tablet, film coated 28.09 mg Current Unavailable Unexpected increase in consumer demand 18/12/2024 sumatriptan succinate Tablet, film coated 140 mg Current Unavailable Manufacturing 18/12/2024 tranexamic acid Injection, solution 1000 mg Anticipated Available Manufacturing 18/12/2024 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 18/12/2024 efmoroctocog alfa Injection, powder for 250 IU Resolved Available Unexpected increase in consumer demand 18/12/2024 paroxetine hydrochloride Tablet, film coated 22.21 mg Anticipated Available Manufacturing 18/12/2024 buprenorphine Drug delivery system, transdermal 5 mg Current Limited Availability Manufacturing 18/12/2024 mesalazine Tablet, enteric coated 800 mg Anticipated Available Manufacturing 18/12/2024 mesalazine Tablet, enteric coated 1.6 g Anticipated Available Manufacturing 18/12/2024 Fremanezumab Injection, solution 225 mg Current Limited Availability Unexpected increase in consumer demand 18/12/2024 clonazepam Tablet, uncoated .5 mg Resolved Available Manufacturing 18/12/2024 estradiol hemihydrate Drug delivery system, transdermal 1.54 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 18/12/2024 estradiol hemihydrate Drug delivery system, transdermal .77 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 18/12/2024 estradiol hemihydrate Drug delivery system, transdermal 3.09 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 18/12/2024 estradiol hemihydrate Drug delivery system, transdermal 2.32 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 18/12/2024 methylphenidate hydrochloride Capsule, modified release 30 mg Anticipated Available Manufacturing 18/12/2024 terbinafine hydrochloride Tablet, uncoated 281.3 mg Resolved Available Manufacturing 17/12/2024 isosorbide dinitrate Tablet, uncoated 5 mg Resolved Available Manufacturing 17/12/2024 fluorouracil Injection, solution 5000 mg Anticipated Available Unexpected increase in consumer demand 17/12/2024 acetylcysteine Injection, concentrated 2 g Current Unavailable Transport / Logistic issues / Storage capacity issues 17/12/2024 olmesartan medoxomil~amlodipine besilate~hydrochlorothiazide Tablet 40 mg~6.944 mg~25 mg Current Limited Availability Manufacturing 17/12/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 17/12/2024 quetiapine fumarate Tablet, film coated 28.78 mg Current Unavailable Manufacturing 17/12/2024 midazolam Injection, solution 5 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 17/12/2024 midazolam Injection, solution 5 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 17/12/2024 rizatriptan benzoate Tablet, orally disintegrating 14.53 mg Current Limited Availability Manufacturing 17/12/2024 prilocaine hydrochloride~felypressin Injection, solution 30 mg/mL~.54 microgram/mL Anticipated Available Manufacturing 17/12/2024 temozolomide Capsule, hard 5 mg Resolved Available Manufacturing 17/12/2024 temozolomide Capsule, hard 20 mg Resolved Available Manufacturing 17/12/2024 temozolomide Capsule, hard 100 mg Resolved Available Transport / Logistic issues / Storage capacity issues 17/12/2024 rosuvastatin calcium Tablet, film coated 10.42 mg Resolved Available Manufacturing 17/12/2024 citalopram hydrobromide Tablet, film coated 49.98 mg Current Limited Availability Manufacturing 17/12/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 17/12/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in consumer demand 17/12/2024 gemeprost Pessary 1 mg Discontinued Reduction in supply until supply is exhausted Manufacturing 17/12/2024 tenofovir disoproxil fumarate~emtricitabine Tablet, film coated 300 mg~200 mg Anticipated Available Manufacturing 17/12/2024 fluorouracil Injection, solution 50 mg/mL Current Limited Availability Manufacturing 17/12/2024 betahistine dihydrochloride Tablet, uncoated 16 mg Resolved Available Manufacturing 17/12/2024 timolol maleate Eye Drops, solution 6.83 mg/mL Current Unavailable Commercial Changes / Commercial viability 17/12/2024 lacosamide Tablet, film coated 50 mg Resolved Available Manufacturing 17/12/2024 pregabalin Capsule, hard 25 mg Current Limited Availability Manufacturing 17/12/2024 Semaglutide Injection, solution 1.34 mg/mL Current Limited Availability Unexpected increase in consumer demand 17/12/2024 Semaglutide Injection, solution 1.34 mg/mL Current Limited Availability Unexpected increase in consumer demand 17/12/2024 olanzapine Tablet, uncoated 2.5 mg Current Unavailable Manufacturing 17/12/2024 methotrexate Tablet 2.5 mg Anticipated Available Manufacturing 17/12/2024 timolol maleate Eye Drops, solution 6.84 mg/mL Current Unavailable Manufacturing 17/12/2024 dorzolamide hydrochloride Eye Drops, solution 22.26 mg/mL Current Unavailable Manufacturing 17/12/2024 clindamycin phosphate Lotion 10 mg/mL Current Unavailable Manufacturing 17/12/2024 famotidine Tablet, film coated 20 mg Current Unavailable Manufacturing 17/12/2024 methylphenidate hydrochloride Tablet, modified release 36 mg Current Limited Availability Manufacturing 17/12/2024 risperidone Tablet, film coated 2 mg Current Limited Availability Unexpected increase in consumer demand 16/12/2024 carboplatin Injection, solution 450 mg Current Limited Availability Manufacturing 16/12/2024 bosentan monohydrate Tablet, film coated 129.08 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 16/12/2024 mesalazine Tablet, enteric coated 250 mg Anticipated Available Manufacturing 16/12/2024 rasagiline mesilate Tablet 1.56 mg Resolved Available Manufacturing 16/12/2024 lacosamide Tablet, film coated 150 mg Resolved Available Transport / Logistic issues / Storage capacity issues 16/12/2024 isavuconazonium sulfate Capsule 186.3 mg Resolved Available Unexpected increase in consumer demand 16/12/2024 furosemide Injection, solution 10 mg/mL Current Limited Availability Transport / Logistic issues / Storage capacity issues 16/12/2024 thiotepa Injection, powder for 15 mg Current Limited Availability Unexpected increase in consumer demand 16/12/2024 levothyroxine sodium Tablet 50 microgram Current Unavailable Manufacturing 16/12/2024 nizatidine Capsule 150 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 16/12/2024 nizatidine Capsule 300 mg Current Limited Availability Manufacturing 16/12/2024 - 2024.12.16
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated tramadol hydrochloride Tablet, modified release 200 mg Current Limited Availability Manufacturing 13/12/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 13/12/2024 entecavir Tablet, film coated .5 mg Current Limited Availability Manufacturing 13/12/2024 prilocaine hydrochloride~felypressin Injection, solution 30 mg/mL~.54 microgram/mL Anticipated Available Manufacturing 13/12/2024 tranexamic acid Injection, solution 1000 mg Current Limited Availability Commercial Changes / Commercial viability 13/12/2024 morphine hydrochloride trihydrate Injection, solution 20 mg/mL Anticipated Available Manufacturing 13/12/2024 ramucirumab Injection, intravenous infusion 100 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 13/12/2024 codeine phosphate hemihydrate~ibuprofen Tablet, film coated 12.8 mg~200 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 13/12/2024 esomeprazole Capsule, enteric 20 mg Anticipated Available Manufacturing 13/12/2024 encorafenib Capsule, hard 75 mg Current Limited Availability Manufacturing 13/12/2024 atorvastatin calcium trihydrate Tablet, film coated 86.751 mg Anticipated Available Manufacturing 13/12/2024 atorvastatin calcium trihydrate Tablet, film coated 43.376 mg Anticipated Available Manufacturing 13/12/2024 pegcetacoplan Injection, solution 1080 mg Current Limited Availability Manufacturing 13/12/2024 rifabutin Capsule, hard 150 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 13/12/2024 doxycycline hyclate Tablet, film coated 57.5 mg Anticipated Available Manufacturing 13/12/2024 olanzapine Injection, powder for 10 mg Current Limited Availability Unexpected increase in consumer demand 13/12/2024 moclobemide Tablet, film coated 150 mg Current Limited Availability Manufacturing 13/12/2024 acetylcholine chloride Solution, powder for irrigation 10 mg/mL Current Unavailable Manufacturing 12/12/2024 ramipril Capsule, hard 1.25 mg Current Limited Availability Manufacturing 12/12/2024 ibuprofen~codeine phosphate hemihydrate Tablet, film coated 200 mg~12.8 mg Discontinued Unavailable Transport / Logistic issues / Storage capacity issues 12/12/2024 mirtazapine Tablet, film coated 45 mg Current Limited Availability Manufacturing 12/12/2024 Somatropin Injection, powder for 12 mg/mL Resolved Available Transport / Logistic issues / Storage capacity issues 12/12/2024 risperidone Tablet, film coated 1 mg Current Limited Availability Unexpected increase in consumer demand 12/12/2024 duloxetine hydrochloride Capsule, enteric 67.32 mg Current Unavailable Commercial Changes / Commercial viability 12/12/2024 drospirenone~ethinylestradiol Tablet, film coated 3 mg~.03 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 12/12/2024 clonazepam Tablet, uncoated .5 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 12/12/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Current Unavailable Manufacturing 12/12/2024 daptomycin Injection, powder for 500 mg Discontinued Unavailable Commercial Changes / Commercial viability 12/12/2024 tamoxifen citrate Tablet 30.34 mg Current Limited Availability Manufacturing 12/12/2024 sitagliptin hydrochloride monohydrate~metformin hydrochloride Tablet, modified release 113.37 mg~1000 mg Current Unavailable Manufacturing 12/12/2024 tamoxifen citrate Tablet, uncoated 15.2 mg Anticipated Available Manufacturing 12/12/2024 prazosin hydrochloride Tablet, uncoated 1.1 mg Current Unavailable Manufacturing 12/12/2024 prazosin hydrochloride Tablet, uncoated 2.2 mg Current Unavailable Manufacturing 12/12/2024 prazosin hydrochloride Tablet, uncoated 5.5 mg Current Unavailable Manufacturing 12/12/2024 nizatidine Capsule 300 mg Current Limited Availability Manufacturing 12/12/2024 nizatidine Capsule, hard 300 mg Anticipated Available Manufacturing 12/12/2024 flecainide acetate Injection, solution 10 mg/mL Current Unavailable Manufacturing 11/12/2024 methylphenidate hydrochloride Tablet, modified release 27 mg Anticipated Available Manufacturing 11/12/2024 fentanyl Drug delivery system, transdermal 8.4 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 11/12/2024 gabapentin Tablet, film coated 600 mg Resolved Available Manufacturing 11/12/2024 azithromycin dihydrate Tablet, film coated 524.1 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 11/12/2024 oxytocin Injection, solution 10 IU Current Unavailable Manufacturing 11/12/2024 cisatracurium besilate Injection, solution 13.4 mg Discontinued Unavailable Commercial Changes / Commercial viability 11/12/2024 simvastatin Tablet, film coated 10 mg Current Limited Availability Manufacturing 11/12/2024 simvastatin Tablet, film coated 80 mg Anticipated Available Manufacturing 11/12/2024 morphine hydrochloride trihydrate Injection, solution 10 mg/mL Anticipated Available Manufacturing 11/12/2024 tenofovir disoproxil maleate Tablet, film coated 300 mg Current Limited Availability Manufacturing 11/12/2024 ezetimibe Tablet, uncoated 10 mg Current Limited Availability Unexpected increase in consumer demand 11/12/2024 nicotinic acid Tablet, uncoated 250 mg Current Unavailable Manufacturing 11/12/2024 ivabradine hydrochloride Tablet, film coated 8.085 mg Anticipated Available Manufacturing 11/12/2024 ezetimibe~atorvastatin calcium trihydrate Tablet, film coated 10 mg~20.681 mg Current Unavailable Manufacturing 11/12/2024 dexmedetomidine hydrochloride Injection, concentrated 118 microgram/mL Current Limited Availability Manufacturing 11/12/2024 naloxone hydrochloride dihydrate Spray, nasal 2.2 mg/actuation Current Limited Availability Manufacturing 11/12/2024 aciclovir Injection, solution 25 mg/mL Resolved Available Unexpected increase in demand due to other sponsors unable to supply 11/12/2024 aciclovir Injection, solution 25 mg/mL Resolved Available Manufacturing 11/12/2024 temozolomide Capsule, hard 5 mg Resolved Available Manufacturing 11/12/2024 methylphenidate hydrochloride Tablet, modified release 54 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 11/12/2024 methylphenidate hydrochloride Tablet, modified release 18 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 11/12/2024 levothyroxine sodium Tablet, uncoated .2 mg Current Limited Availability Manufacturing 11/12/2024 tirzepatide Injection, solution 5 mg Current Unavailable Commercial Changes / Commercial viability 11/12/2024 metformin hydrochloride Tablet, film coated 850 mg Current Unavailable Manufacturing 11/12/2024 metformin hydrochloride Tablet, film coated 1000 mg Current Unavailable Manufacturing 11/12/2024 methylphenidate hydrochloride Tablet, modified release 36 mg Anticipated Available Manufacturing 11/12/2024 lidocaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrate Injection, solution 21.3 mg/mL~22.7 microgram/mL Anticipated Available Manufacturing 10/12/2024 hydrocortisone acetate Eye Ointment 10 mg/g Current Unavailable Manufacturing 10/12/2024 morphine hydrochloride trihydrate Oral Liquid, solution 5 mg/mL Resolved Available Commercial Changes / Commercial viability 10/12/2024 losartan potassium Tablet, film coated 50 mg Current Limited Availability Manufacturing 10/12/2024 losartan potassium Tablet, film coated 25 mg Current Limited Availability Manufacturing 10/12/2024 heparin sodium Injection, solution 25000 IU/mL Anticipated Available Manufacturing 10/12/2024 duloxetine hydrochloride Capsule, enteric 33.65 mg Discontinued Unavailable Manufacturing 10/12/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Discontinued Unavailable Manufacturing 10/12/2024 duloxetine hydrochloride Capsule, enteric 33.66 mg Current Unavailable Unexpected increase in consumer demand 10/12/2024 efmoroctocog alfa Injection, powder for 250 IU Current Unavailable Unexpected increase in consumer demand 10/12/2024 candesartan cilexetil Tablet, uncoated 4 mg Current Limited Availability Manufacturing 10/12/2024 tranexamic acid Injection, solution 100 mg/mL Current Limited Availability Manufacturing 10/12/2024 azithromycin dihydrate Tablet, film coated 524 mg Current Limited Availability Manufacturing 10/12/2024 nizatidine Capsule, hard 150 mg Current Unavailable Manufacturing 10/12/2024 atorvastatin calcium trihydrate Tablet, film coated 86.76 mg Current Limited Availability Manufacturing 10/12/2024 tenofovir disoproxil fumarate Tablet 300 mg Resolved Available Manufacturing 10/12/2024 levetiracetam Tablet, film coated 1000 mg Resolved Available Manufacturing 10/12/2024 nebivolol hydrochloride Tablet 5.45 mg Resolved Available Manufacturing 10/12/2024 trimethoprim Tablet, uncoated 300 mg Current Limited Availability Manufacturing 10/12/2024 sitagliptin fumarate Tablet, film coated 32.124 mg Current Unavailable Manufacturing 10/12/2024 olmesartan medoxomil~amlodipine besilate Tablet, film coated 40 mg~13.88 mg Current Unavailable Manufacturing 10/12/2024 methylphenidate hydrochloride Tablet, modified release 36 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 10/12/2024 methylphenidate hydrochloride Tablet, modified release 27 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 10/12/2024 melatonin Capsule, hard 5 mg Current Limited Availability Unexpected increase in consumer demand 10/12/2024 melatonin Oral Liquid, solution 1 mg/mL Current Limited Availability Unexpected increase in consumer demand 10/12/2024 fosinopril sodium Tablet, uncoated 10 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 10/12/2024 droperidol Injection, solution 2.5 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 10/12/2024 albendazole Tablet, chewable 200 mg Current Unavailable Manufacturing 10/12/2024 cisatracurium besilate Injection, solution 6.7 mg/mL Current Unavailable Manufacturing 10/12/2024 azithromycin dihydrate Tablet, film coated 628.93 mg Current Unavailable Manufacturing 10/12/2024 norethisterone acetate~estradiol Drug delivery system, transdermal 2.7 mg~.62 mg Current Limited Availability Manufacturing 10/12/2024 adrenaline (epinephrine) acid tartrate Injection, solution 1.82 mg/mL Current Limited Availability Manufacturing 9/12/2024 pantoprazole sodium sesquihydrate Injection, powder for 45.12 mg Discontinued Unavailable Manufacturing 9/12/2024 acetylcysteine Injection, concentrated 2 g Current Limited Availability Transport / Logistic issues / Storage capacity issues 9/12/2024 tobramycin Injection, solution 40 mg/mL Current Limited Availability Unexpected increase in consumer demand 9/12/2024 noradrenaline (norepinephrine) acid tartrate monohydrate Injection, concentrated 2 mg/mL Resolved Available Transport / Logistic issues / Storage capacity issues 9/12/2024 adrenaline (epinephrine) acid tartrate Injection, solution 1.819 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 9/12/2024 hydromorphone hydrochloride Injection, solution 2 mg Resolved Available Manufacturing 9/12/2024 Fremanezumab Injection, solution 225 mg Anticipated Available Unexpected increase in consumer demand 9/12/2024 sodium amidotrizoate~amidotrizoate meglumine Injection, intravenous infusion 40 mg/mL~260 mg/mL Resolved Available Manufacturing 9/12/2024 clarithromycin Oral Liquid, powder for 50 mg/mL Resolved Available Unexpected increase in consumer demand 9/12/2024 - 2024.12.09
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated bupivacaine hydrochloride Injection, solution 5 mg/mL Current Unavailable Manufacturing 6/12/2024 lidocaine hydrochloride Injection, solution 10 mg/mL Current Unavailable Manufacturing 6/12/2024 finasteride Tablet, film coated 1 mg Resolved Available Unexpected increase in consumer demand 6/12/2024 docetaxel Injection, concentrated 80 mg Current Limited Availability Manufacturing 6/12/2024 noradrenaline (norepinephrine) acid tartrate monohydrate Injection, concentrated 8 mg Current Unavailable Manufacturing 6/12/2024 clonidine hydrochloride Tablet 100 microgram Current Unavailable Unexpected increase in consumer demand 6/12/2024 adenosine Solution 30 mg Current Limited Availability Manufacturing 6/12/2024 lorazepam Tablet 2.5 mg Anticipated Available Manufacturing 6/12/2024 estradiol hemihydrate Drug delivery system, transdermal 1.54 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 6/12/2024 estradiol hemihydrate Drug delivery system, transdermal .77 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 6/12/2024 estradiol hemihydrate Drug delivery system, transdermal 3.09 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 6/12/2024 estradiol hemihydrate Drug delivery system, transdermal 2.32 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 6/12/2024 olanzapine Injection, powder for 10 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 6/12/2024 amlodipine besilate Tablet, uncoated 6.94 mg Current Limited Availability Manufacturing 5/12/2024 duloxetine hydrochloride Capsule, enteric 33.65 mg Discontinued Unavailable Manufacturing 5/12/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Discontinued Unavailable Manufacturing 5/12/2024 rasagiline mesilate Tablet 1.56 mg Resolved Available Manufacturing 5/12/2024 letrozole Tablet, film coated 2.5 mg Resolved Available Manufacturing 5/12/2024 nebivolol hydrochloride Tablet 1.363 mg Current Limited Availability Manufacturing 5/12/2024 nebivolol hydrochloride Tablet 5.45 mg Current Unavailable Manufacturing 5/12/2024 gemfibrozil Tablet, film coated 600 mg Current Limited Availability Manufacturing 5/12/2024 metformin hydrochloride Tablet, film coated 850 mg Current Unavailable Manufacturing 5/12/2024 nizatidine Capsule 150 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 5/12/2024 nizatidine Capsule 300 mg Current Limited Availability Manufacturing 5/12/2024 moclobemide Tablet, film coated 150 mg Current Limited Availability Manufacturing 5/12/2024 testosterone enantate Injection 250 mg/mL Anticipated Available Unexpected increase in consumer demand 4/12/2024 acetylcysteine Injection, concentrated 2 g Current Limited Availability Manufacturing 4/12/2024 sodium fluoride Injection, concentrated 1 mg/mL Current Limited Availability Manufacturing 4/12/2024 fentanyl Drug delivery system, transdermal 2.1 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 4/12/2024 fentanyl Drug delivery system, transdermal 16.8 mg Anticipated Available Manufacturing 4/12/2024 dopamine hydrochloride Injection, concentrated 40 mg/mL Current Limited Availability Manufacturing 4/12/2024 hydrochlorothiazide~telmisartan Tablet, film coated 12.5 mg~80 mg Resolved Available Manufacturing 4/12/2024 acarbose Tablet 100 mg Current Unavailable Manufacturing 4/12/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 4/12/2024 tadalafil Tablet, film coated 5 mg Current Unavailable Manufacturing 4/12/2024 lamotrigine Tablet, chewable 100 mg Anticipated Available Unexpected increase in consumer demand 4/12/2024 lamotrigine Tablet, chewable 200 mg Anticipated Available Unexpected increase in consumer demand 4/12/2024 midazolam Injection, solution 1 mg/mL Resolved Available Manufacturing 4/12/2024 tobramycin Inhalation, conventional 60 mg/mL Resolved Available Manufacturing 4/12/2024 bupivacaine hydrochloride monohydrate Injection, solution 52.7 mg Resolved Available Manufacturing 3/12/2024 topiramate Tablet, film coated 50 mg Anticipated Available Manufacturing 3/12/2024 olanzapine pamoate monohydrate Injection, powder for 931 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 3/12/2024 olanzapine pamoate monohydrate Injection, powder for 690 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 3/12/2024 olanzapine pamoate monohydrate Injection, powder for 483 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 3/12/2024 benzathine benzylpenicillin tetrahydrate Injection, suspension 1200000 USP Unit Current Limited Availability Manufacturing 3/12/2024 azithromycin dihydrate Tablet, film coated 524.1 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 3/12/2024 silver sulfadiazine Cream 10 mg/g Current Unavailable Manufacturing 3/12/2024 silver sulfadiazine Cream 10 mg/g Current Unavailable Manufacturing 3/12/2024 risperidone Tablet, film coated 1 mg Current Unavailable Manufacturing 3/12/2024 carbidopa monohydrate~entacapone~levodopa Tablet, film coated 33.75 mg~200 mg~125 mg Anticipated Available Manufacturing 3/12/2024 midazolam Injection, solution 5 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 3/12/2024 midazolam Injection, solution 5 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 3/12/2024 desvenlafaxine Tablet, modified release 50 mg Anticipated Available Manufacturing 3/12/2024 temozolomide Capsule, hard 20 mg Current Unavailable Manufacturing 3/12/2024 ezetimibe Tablet, uncoated 10 mg Current Limited Availability Manufacturing 3/12/2024 hydromorphone hydrochloride Injection, solution 2 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 3/12/2024 tadalafil Tablet, film coated 10 mg Anticipated Available Manufacturing 3/12/2024 nebivolol hydrochloride Tablet 5.45 mg Anticipated Available Manufacturing 3/12/2024 nizatidine Capsule, hard 150 mg Current Unavailable Manufacturing 3/12/2024 tadalafil Tablet, film coated 5 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 3/12/2024 tenofovir disoproxil fumarate Tablet 300 mg Current Unavailable Manufacturing 3/12/2024 pregabalin Capsule, hard 75 mg Anticipated Available Unexpected increase in consumer demand 3/12/2024 nebivolol hydrochloride Tablet 5.45 mg Current Limited Availability Manufacturing 3/12/2024 nebivolol hydrochloride Tablet 5.45 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 3/12/2024 aciclovir Injection, solution 25 mg/mL Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 3/12/2024 thiotepa Injection, powder for 15 mg Resolved Available Unexpected increase in consumer demand 3/12/2024 lanreotide acetate Injection, solution 66.67 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 3/12/2024 melatonin Capsule, hard 5 mg Current Limited Availability Unexpected increase in consumer demand 3/12/2024 dabigatran etexilate mesilate Capsule 86.475 mg Resolved Available Manufacturing 3/12/2024 aciclovir Injection, solution 25 mg/mL Current Unavailable Manufacturing 3/12/2024 clonidine hydrochloride Tablet, uncoated 150 microgram Resolved Available Manufacturing 3/12/2024 quinapril hydrochloride~hydrochlorothiazide Tablet, film coated 10.832 mg~12.5 mg Current Unavailable Manufacturing 3/12/2024 hydrochlorothiazide~quinapril hydrochloride Tablet, film coated 12.5 mg~21.664 mg Current Unavailable Manufacturing 3/12/2024 esomeprazole sodium Injection, powder for 42.5 mg Resolved Available Manufacturing 3/12/2024 anidulafungin Injection, powder for 100 mg Resolved Available Manufacturing 2/12/2024 pentetic acid Injection, powder for 5 mg Current Emergency Supply Only Manufacturing 2/12/2024 medronic acid Injection, powder for 10 mg Current Limited Availability Manufacturing 2/12/2024 papaverine hydrochloride Injection, solution 12 mg/mL Resolved Available Manufacturing 2/12/2024 tacrolimus monohydrate Capsule, hard 1.022 mg Resolved Available Manufacturing 2/12/2024 levetiracetam Tablet, film coated 250 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 2/12/2024 levetiracetam Tablet, film coated 500 mg Anticipated Available Manufacturing 2/12/2024 acetylcysteine Injection, concentrated 2 g Current Limited Availability Transport / Logistic issues / Storage capacity issues 2/12/2024 diazepam Tablet, uncoated 2 mg Current Limited Availability Manufacturing 2/12/2024 galantamine hydrobromide Capsule, modified release 20.504 mg Anticipated Available Manufacturing 2/12/2024 sumatriptan succinate Tablet, film coated 69.99 mg Resolved Available Unexpected increase in consumer demand 2/12/2024 hydrochlorothiazide~olmesartan medoxomil Tablet, film coated 25 mg~40 mg Resolved Available Manufacturing 2/12/2024 fenofibrate Tablet 48 mg Anticipated Available Manufacturing 2/12/2024 azithromycin dihydrate Tablet, film coated 524 mg Current Unavailable Manufacturing 2/12/2024 acamprosate calcium Tablet, enteric coated 333 mg Anticipated Available Manufacturing 2/12/2024 dasatinib Tablet, film coated 50 mg Resolved Available Manufacturing 2/12/2024 dasatinib Tablet, film coated 100 mg Resolved Available Manufacturing 2/12/2024 dasatinib Tablet, film coated 70 mg Resolved Available Commercial Changes / Commercial viability 2/12/2024 atomoxetine hydrochloride Capsule, hard 114 mg Anticipated Available Manufacturing 2/12/2024 benzathine benzylpenicillin tetrahydrate Injection, suspension 600000 USP Unit Current Unavailable Manufacturing 2/12/2024 lacosamide Tablet, film coated 50 mg Current Limited Availability Manufacturing 2/12/2024 lacosamide Tablet, film coated 150 mg Resolved Available Manufacturing 2/12/2024 levetiracetam Tablet, film coated 1000 mg Current Unavailable Manufacturing 2/12/2024 pregabalin Capsule, hard 150 mg Resolved Available Manufacturing 2/12/2024 fentanyl citrate Injection, solution 157 microgram Current Unavailable Manufacturing 2/12/2024 erythromycin ethyl succinate Oral Liquid, powder for 468 mg Resolved Available Unexpected increase in consumer demand 2/12/2024 clindamycin phosphate Cream 22.8 mg/g Resolved Available Transport / Logistic issues / Storage capacity issues 2/12/2024 ciprofloxacin hydrochloride Tablet, film coated 873.32 mg Current Limited Availability Manufacturing 2/12/2024 methylphenidate hydrochloride Capsule, modified release 40 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 2/12/2024 - 2024.12.02
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated sodium fluoride Injection, concentrated 1 mg/mL Anticipated Available Manufacturing 1/12/2024 acarbose Tablet 100 mg Anticipated Available Manufacturing 1/12/2024 rasagiline mesilate Tablet, uncoated 1.56 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 1/12/2024 testosterone enantate Injection 250 mg/mL Anticipated Available Unexpected increase in consumer demand 29/11/2024 bupivacaine hydrochloride Injection, solution 5 mg/mL Anticipated Available Manufacturing 29/11/2024 topiramate Tablet, film coated 200 mg Current Limited Availability Manufacturing 29/11/2024 timolol maleate Eye Drops, solution 6.83 mg/mL Current Limited Availability Commercial Changes / Commercial viability 29/11/2024 levothyroxine sodium Tablet, uncoated .05 mg Resolved Available Manufacturing 29/11/2024 levothyroxine sodium Tablet, uncoated .075 mg Resolved Available Manufacturing 29/11/2024 levothyroxine sodium Tablet, uncoated .1 mg Resolved Available Manufacturing 29/11/2024 levothyroxine sodium Tablet, uncoated .2 mg Resolved Available Manufacturing 29/11/2024 clonazepam Tablet, uncoated 2 mg Resolved Available Manufacturing 29/11/2024 norethisterone~ethinylestradiol Tablet, uncoated 1 mg~36 microgram Current Limited Availability Manufacturing 29/11/2024 metformin hydrochloride Tablet, film coated 500 mg Current Limited Availability Manufacturing 29/11/2024 metformin hydrochloride Tablet, film coated 1000 mg Current Unavailable Manufacturing 29/11/2024 nizatidine Capsule 300 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 29/11/2024 chlorhexidine gluconate Solution, irrigation 30 mg Current Limited Availability Manufacturing 28/11/2024 methylphenidate hydrochloride Tablet, modified release 27 mg Anticipated Available Manufacturing 28/11/2024 sodium pyrophosphate Injection, powder for 30 mg Current Unavailable Manufacturing 28/11/2024 phenoxymethylpenicillin potassium Tablet, film coated 280 mg Current Limited Availability Manufacturing 28/11/2024 quetiapine fumarate Tablet, film coated 28.78 mg Current Limited Availability Manufacturing 28/11/2024 metoprolol succinate Tablet, modified release 190 mg Current Limited Availability Manufacturing 28/11/2024 esomeprazole magnesium dihydrate Tablet, enteric coated 21.75 mg Resolved Available Transport / Logistic issues / Storage capacity issues 28/11/2024 ezetimibe~atorvastatin calcium trihydrate Tablet, multilayer 10 mg~21.7 mg Current Unavailable Manufacturing 28/11/2024 atorvastatin calcium trihydrate~ezetimibe Tablet, multilayer 43.4 mg~10 mg Current Unavailable Manufacturing 28/11/2024 atorvastatin calcium trihydrate~ezetimibe Tablet, multilayer 86.8 mg~10 mg Current Unavailable Manufacturing 28/11/2024 methylphenidate hydrochloride Capsule, modified release 60 mg Resolved Available Transport / Logistic issues / Storage capacity issues 28/11/2024 betahistine dihydrochloride Tablet, uncoated 16 mg Current Limited Availability Manufacturing 28/11/2024 cinacalcet hydrochloride Tablet 99.191 mg Current Limited Availability Manufacturing 28/11/2024 deferasirox Tablet, film coated 360 mg Current Unavailable Manufacturing 28/11/2024 paracetamol Tablet, modified release 665 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 28/11/2024 melatonin Oral Liquid, solution 1 mg/mL Current Limited Availability Unexpected increase in consumer demand 28/11/2024 lidocaine hydrochloride monohydrate Injection, solution 20 mg/mL Resolved Available Manufacturing 28/11/2024 lidocaine hydrochloride monohydrate Injection, solution 10 mg/mL Resolved Available Manufacturing 28/11/2024 verapamil hydrochloride Tablet, modified release 180 mg Resolved Available Manufacturing 28/11/2024 clonazepam Tablet, uncoated .5 mg Current Unavailable Manufacturing 28/11/2024 clarithromycin Oral Liquid, powder for 50 mg/mL Current Limited Availability Unexpected increase in consumer demand 28/11/2024 methylphenidate hydrochloride Tablet, modified release 18 mg Current Limited Availability Manufacturing 28/11/2024 methylphenidate hydrochloride Tablet, modified release 36 mg Anticipated Available Manufacturing 28/11/2024 methylphenidate hydrochloride Tablet, modified release 54 mg Current Limited Availability Manufacturing 28/11/2024 pravastatin sodium Tablet, uncoated 40 mg Current Unavailable Manufacturing 28/11/2024 norethisterone Tablet, uncoated 350 microgram Current Unavailable Manufacturing 27/11/2024 gabapentin Capsule, hard 300 mg Anticipated Available Manufacturing 27/11/2024 gentamicin Injection, solution 80 mg Current Unavailable Manufacturing 27/11/2024 montelukast sodium Tablet, chewable 5.2 mg Current Unavailable Manufacturing 27/11/2024 hydrochlorothiazide~valsartan Tablet, film coated 25 mg~320 mg Resolved Available Manufacturing 27/11/2024 duloxetine hydrochloride Capsule, enteric 33.65 mg Resolved Available Manufacturing 27/11/2024 betahistine dihydrochloride Tablet 24 mg Current Unavailable Unexpected increase in consumer demand 27/11/2024 ezetimibe Tablet 10 mg Current Unavailable Manufacturing 27/11/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in consumer demand 27/11/2024 montelukast sodium Tablet, chewable 5.2 mg Current Unavailable Manufacturing 27/11/2024 trimethoprim Tablet, uncoated 300 mg Resolved Available Manufacturing 27/11/2024 sitagliptin hydrochloride monohydrate Tablet, film coated 109 mg Current Unavailable Manufacturing 27/11/2024 sitagliptin hydrochloride monohydrate Tablet, film coated 54.5 mg Current Unavailable Manufacturing 27/11/2024 sitagliptin hydrochloride monohydrate Tablet, film coated 27.25 mg Current Unavailable Manufacturing 27/11/2024 prazosin hydrochloride Tablet, uncoated 5.476 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 26/11/2024 Somatropin Injection, powder for 12 mg/mL Current Unavailable Transport / Logistic issues / Storage capacity issues 26/11/2024 rosuvastatin calcium Tablet, film coated 10.42 mg Anticipated Available Manufacturing 26/11/2024 tenofovir disoproxil maleate~emtricitabine Tablet, film coated 300 mg~200 mg Current Unavailable Manufacturing 26/11/2024 tenofovir disoproxil fumarate~emtricitabine Tablet, film coated 300 mg~200 mg Anticipated Available Manufacturing 26/11/2024 atorvastatin calcium trihydrate Tablet, film coated 86.76 mg Anticipated Available Manufacturing 26/11/2024 ropinirole hydrochloride Tablet, film coated .285 mg Anticipated Available Manufacturing 26/11/2024 aciclovir Injection, solution 25 mg/mL Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 26/11/2024 aciclovir Injection, solution 25 mg/mL Current Unavailable Manufacturing 26/11/2024 oseltamivir phosphate Capsule, hard 98.524 mg Resolved Available Unexpected increase in consumer demand 26/11/2024 olmesartan medoxomil~amlodipine besilate Tablet, film coated 40 mg~6.94 mg Current Unavailable Unexpected increase in consumer demand 26/11/2024 dasatinib Tablet, film coated 50 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 26/11/2024 heparin sodium Injection, solution 5000 IU/mL Current Unavailable Manufacturing 26/11/2024 ciprofloxacin hydrochloride Tablet, film coated 873.32 mg Current Limited Availability Manufacturing 26/11/2024 acetylcysteine Injection, concentrated 2 g Anticipated Available Manufacturing 25/11/2024 fluticasone furoate Spray, suspension 27.5 microgram Resolved Available Unexpected increase in consumer demand 25/11/2024 amoxicillin trihydrate~potassium clavulanate Suspension, powder for 28.7 mg/mL~7.45 mg/mL Resolved Available Manufacturing 25/11/2024 ibuprofen~codeine phosphate hemihydrate Tablet, film coated 200 mg~12.8 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 25/11/2024 tacrolimus monohydrate Capsule, hard 1.022 mg Current Limited Availability Manufacturing 25/11/2024 dexamethasone sodium phosphate Injection, solution 4.37 mg/mL Resolved Available Manufacturing 25/11/2024 levodopa~carbidopa monohydrate~entacapone Tablet, film coated 125 mg~33.75 mg~200 mg Anticipated Available Manufacturing 25/11/2024 voriconazole Injection, powder for 200 mg Current Unavailable Manufacturing 25/11/2024 ezetimibe Tablet, uncoated 10 mg Anticipated Available Manufacturing 25/11/2024 irbesartan~hydrochlorothiazide Tablet, film coated 300 mg~25 mg Current Unavailable Manufacturing 25/11/2024 nebivolol hydrochloride Tablet 10.9 mg Resolved Available Manufacturing 25/11/2024 nebivolol hydrochloride Tablet 1.363 mg Resolved Available Manufacturing 25/11/2024 levetiracetam Tablet, film coated 1000 mg Current Unavailable Manufacturing 25/11/2024 olanzapine Tablet, uncoated 2.5 mg Anticipated Available Manufacturing 25/11/2024 heparin sodium Injection, solution 1000 IU/mL Current Limited Availability Manufacturing 25/11/2024
ドイツ
- 2024.12.30
Active ingredients Type of reason Message type Date of the last message Hydrochlorothiazide; Valsartan Other Change notification 29.12.2024 Risperidone Other Initial notification 27.12.2024 Clarithromycin Other Change notification 27.12.2024 Medroxyprogesterone acetate Other Change notification 27.12.2024 Ciprofloxacin hydrochloride (1:1) 1 H<2>O Other Change notification 27.12.2024 Sodium valproate; valproic acid Other Change notification 27.12.2024 Flunarizine dihydrochloride Production problem Change notification 27.12.2024 Flucloxacillin sodium 1 H<2>O Production problem Change notification 27.12.2024 Levetiracetam Production problem Change notification 27.12.2024 Metronidazole Production problem Change notification 23.12.2024 Atomoxetine hydrochloride Production problem Change notification 23.12.2024 - 2024.12.23
Active ingredients Type of reason Message type Date of the last message Caffeine; Paracetamol Production problem Initial notification 21.12.2024 Vancomycin hydrochloride Other Initial notification 20.12.2024 Emtricitabine; tenofovir disoproxil maleate Other Initial notification 20.12.2024 Clomipramine hydrochloride Production problem Initial notification 20.12.2024 Fomepizole hemisulfate Other Initial notification 20.12.2024 Urapidil Other Change notification 20.12.2024 Flunisolide hemihydrate Other Change notification 20.12.2024 Teicoplanin Other Initial notification 20.12.2024 Fluconazole Other Change notification 20.12.2024 Salbutamol sulfate Other Change notification 19.12.2024 Etoposide Production problem Initial notification 19.12.2024 Verteporfin Other Change notification 19.12.2024 Cyclophosphamide monohydrate Other Initial notification 19.12.2024 Valsartan Production problem Initial notification 19.12.2024 Copper tetramibitetrafluoroborate Other Initial notification 19.12.2024 Risperidone Production problem Change notification 19.12.2024 Phenoxymethylpenicillin potassium Production problem Change notification 19.12.2024 Oxazepam Other Change notification 19.12.2024 Metoprolol tartrate (Ph.Eur.) Other Change notification 19.12.2024 Hydromorphone hydrochloride Other Change notification 19.12.2024 Ciprofloxacin hydrochloride (1:1) 1 H<2>O Other Change notification 19.12.2024 Buprenorphine Other Change notification 19.12.2024 Amoxicillin trihydrate; potassium clavulanate Other Change notification 19.12.2024 Amoxicillin trihydrate Other Change notification 19.12.2024 Ipratropium bromide (Ph.Eur.) Production problem Change notification 19.12.2024 Phenytoin Other Change notification 19.12.2024 Buprenorphine Other Change notification 19.12.2024 Ciprofloxacin hydrochloride (1:1) 1 H<2>O Other Change notification 19.12.2024 Oxazepam Other Change notification 19.12.2024 Hydromorphone hydrochloride Other Change notification 19.12.2024 Timolol maleate Production problem Change notification 19.12.2024 Gentamicin sulphate Production problem Change notification 19.12.2024 Sodium cromoglicate (Ph.Eur.); reproterol hydrochloride Production problem Change notification 18.12.2024 Quetiapine fumarate (Ph.Eur.) Other Initial notification 17.12.2024 Vibegron Production problem Change notification 17.12.2024 Hydrocortisone Other Initial notification 17.12.2024 Atomoxetine hydrochloride Production problem Change notification 17.12.2024 Liraglutide Other Change notification 17.12.2024 Atomoxetine hydrochloride Production problem Change notification 17.12.2024 Minocycline hydrochloride ((anhydrous, not pharmacopoeia compliant)) Other Change notification 17.12.2024 Cinacalcethydrochloride Other Change notification 17.12.2024 Azithromycin dihydrate Other Change notification 17.12.2024 Cefixime 3 H<2>O Other Change notification 17.12.2024 Cinacalcethydrochloride Other Change notification 17.12.2024 Indapamide; perindopril-tert-butylamine Other Change notification 17.12.2024 Phenoxymethylpenicillin potassium Production problem Change notification 17.12.2024 Selegiline hydrochloride Other Change notification 17.12.2024 Doxycycline hyclate Other Change notification 17.12.2024 Metformin hydrochloride; sitagliptin hydrochloride monohydrate Other Change notification 17.12.2024 Adenosine Production problem Change notification 17.12.2024 Etoricoxib Other Change notification 17.12.2024 Methotrexate disodium Other Initial notification 16.12.2024 Remifentanil hydrochloride Other Change notification 16.12.2024 Atomoxetine hydrochloride Production problem Change notification 16.12.2024 - 2024.12.16
Active ingredients Type of reason Message type Date of the last message Oxycodone hydrochloride (Ph.Eur.) Other Initial notification 13.12.2024 Galantamine hydrobromide Production problem Change notification 13.12.2024 Ezetimibe; Simvastatin Production problem Change notification 13.12.2024 Mometasone furoate (Ph.Eur.) Production problem Change notification 13.12.2024 Phenprocoumon Production problem Change notification 13.12.2024 Pramipexole dihydrochloride monohydrate Other Initial notification 13.12.2024 Gentamicin sulphate Production problem Initial notification 13.12.2024 Gentamicin sulphate Production problem Change notification 13.12.2024 Atomoxetine hydrochloride Production problem Change notification 13.12.2024 Salbutamol sulfate Other Change notification 13.12.2024 Iron(III) sodium D-gluconate hydroxide oxide complex (approx. 2:1:1:x:y) Other Change notification 13.12.2024 Pramipexole dihydrochloride monohydrate Other Initial notification 13.12.2024 Doxorubicin hydrochloride Other Initial notification 12.12.2024 Clarithromycin Other Change notification 12.12.2024 Amoxicillin trihydrate Other Change notification 12.12.2024 Tamoxifen citrate Other Change notification 12.12.2024 Oxazepam Other Change notification 12.12.2024 Vancomycin hydrochloride Production problem Change notification 12.12.2024 Fluorouracil Other Change notification 12.12.2024 Lanthanum(III) carbonate x H<2>O Other Change notification 12.12.2024 Pramipexole dihydrochloride monohydrate Other Initial notification 12.12.2024 Isosorbide mononitrate Other Initial notification 12.12.2024 Sugammadex sodium Production problem Change notification 12.12.2024 Hydroxocobalamin Production problem Initial notification 11.12.2024 Sotalol hydrochloride Production problem Initial notification 11.12.2024 Buspirone hydrochloride Other Initial notification 11.12.2024 Pramipexole dihydrochloride monohydrate Other Initial notification 11.12.2024 Pramipexole dihydrochloride monohydrate Production problem Change notification 11.12.2024 Sodium hydrogen carbonate Other Change notification 11.12.2024 Doxorubicin hydrochloride Production problem Initial notification 11.12.2024 Domperidone Production problem Initial notification 11.12.2024 Acemetacin Production problem Change notification 11.12.2024 Isosorbide mononitrate Other Initial notification 11.12.2024 Itraconazole Other Change notification 11.12.2024 Sodium valproate; valproic acid Other Change notification 11.12.2024 Hydromorphone hydrochloride Other Change notification 11.12.2024 Isoniazid Production problem Initial notification 11.12.2024 Progesterone Production problem Change notification 11.12.2024 Pork pancreas powder Other Initial notification 10.12.2024 Oxaliplatin Other Initial notification 10.12.2024 Methotrexate disodium Other Initial notification 10.12.2024 Phenobarbital Other Initial notification 10.12.2024 Fluphenazine decanoate Production problem Change notification 10.12.2024 Etoposide Production problem Change notification 10.12.2024 Doxorubicin hydrochloride Other Initial notification 10.12.2024 Cisplatin Other Initial notification 10.12.2024 Phenoxymethylpenicillin potassium Other Initial notification 09.12.2024 Alprostadil Other Change notification 09.12.2024 Phenoxymethylpenicillin potassium Other Change notification 09.12.2024 - 2024.12.09
Active ingredients Type of reason Message type Date of the last message Hydrocortisone acetate (Ph.Eur.) Production problem Change notification 08.12.2024 Mitomycin Other Change notification 06.12.2024 Olanzapine Production problem Initial notification 06.12.2024 Idarubicin hydrochloride Other Change notification 06.12.2024 Sodium valproate; valproic acid Other Change notification 06.12.2024 Clarithromycin Other Change notification 06.12.2024 Clarithromycin Other Change notification 06.12.2024 Ciprofloxacin hydrochloride (1:1) 1 H<2>O Other Change notification 06.12.2024 Ciprofloxacin hydrochloride (1:1) 1 H<2>O Other Change notification 06.12.2024 Azithromycin dihydrate Other Change notification 06.12.2024 Phenoxymethylpenicillin potassium Other Change notification 06.12.2024 Olanzapine embonate monohydrate Production problem Change notification 06.12.2024 Fluorouracil Other Initial notification 06.12.2024 Tobramycin Production problem Initial notification 06.12.2024 Gentamicin sulphate Production problem Initial notification 06.12.2024 Dexamethasone dihydrogen phosphate disodium (Ph.Eur.) Production problem Initial notification 06.12.2024 Insulin aspart Other Initial notification 05.12.2024 Insulin aspart Other Initial notification 05.12.2024 Turoctocog alfa pegol Other Initial notification 05.12.2024 Fludarabine phosphate (Ph.Eur.) Other Initial notification 05.12.2024 Carbamazepine Other Initial notification 05.12.2024 Isosorbide mononitrate Production problem Initial notification 05.12.2024 Isosorbide mononitrate Production problem Initial notification 05.12.2024 Isosorbide mononitrate Production problem Initial notification 05.12.2024 Caspofungin diacetate Other Change notification 05.12.2024 Isosorbide mononitrate Other Initial notification 05.12.2024 Isosorbide mononitrate Other Initial notification 05.12.2024 Citric acid bismuth potassium salt (2:1:5) x H<2>O; metronidazole; tetracycline hydrochloride Other Change notification 05.12.2024 Cabergoline Other Initial notification 05.12.2024 Hydrochlorothiazide; quinapril hydrochloride Other Change notification 04.12.2024 Hydrochlorothiazide; quinapril hydrochloride Other Change notification 04.12.2024 Quinapril hydrochloride Other Change notification 04.12.2024 Hydrochlorothiazide; quinapril hydrochloride Other Change notification 04.12.2024 Quinapril hydrochloride Other Change notification 04.12.2024 Quinapril hydrochloride Other Change notification 04.12.2024 Phenprocoumon Production problem Change notification 04.12.2024 Betamethasone dipropionate (Ph.Eur.); calcipotriol monohydrate Other Initial notification 04.12.2024 Fusidic acid (Ph.Eur.) Other Initial notification 04.12.2024 Hydrocortisone Other Initial notification 04.12.2024 Erythromycin Other Initial notification 04.12.2024 Prednicarbate Other Change notification 04.12.2024 Clobetasol propionate (Ph.Eur.) Other Change notification 04.12.2024 Buprenorphine Other Change notification 04.12.2024 Buprenorphine Other Change notification 04.12.2024 Buprenorphine Other Change notification 04.12.2024 Azithromycin dihydrate Other Change notification 04.12.2024 Risperidone Production problem Change notification 04.12.2024 Risperidone Production problem Change notification 04.12.2024 Risperidone Production problem Change notification 04.12.2024 Phenoxymethylpenicillin potassium Production problem Change notification 04.12.2024 Hydromorphone hydrochloride Other Change notification 04.12.2024 Lamotrigine Production problem Change notification 04.12.2024 Hydromorphone hydrochloride Other Change notification 04.12.2024 Hydromorphone hydrochloride Other Change notification 04.12.2024 Hydromorphone hydrochloride Other Change notification 04.12.2024 Hydromorphone hydrochloride Other Change notification 04.12.2024 Hydromorphone hydrochloride Other Change notification 04.12.2024 Buprenorphine Other Change notification 04.12.2024 Buprenorphine Other Change notification 04.12.2024 Buprenorphine Other Change notification 04.12.2024 Buprenorphine Other Change notification 04.12.2024 Amoxicillin trihydrate; potassium clavulanate Other Change notification 04.12.2024 Amoxicillin trihydrate Other Change notification 04.12.2024 Hydromorphone hydrochloride Other Initial notification 04.12.2024 Hydromorphone hydrochloride Production problem Change notification 04.12.2024 Hydromorphone hydrochloride Production problem Change notification 04.12.2024 Azithromycin dihydrate Other Change notification 04.12.2024 Estradiol hemihydrate; norethisterone acetate Other Initial notification 04.12.2024 Estradiol hemihydrate; norethisterone acetate Other Initial notification 04.12.2024 Pramipexole dihydrochloride monohydrate Other Initial notification 03.12.2024 Pramipexole dihydrochloride monohydrate Other Initial notification 03.12.2024 Cyclopentolate hydrochloride Production problem Change notification 03.12.2024 Acetylcholine chloride Production problem Change notification 03.12.2024 Hydromorphone hydrochloride Other Initial notification 03.12.2024 Morphine sulphate (Ph.Eur.) Other Initial notification 03.12.2024 Mivacurium chloride Production problem Change notification 03.12.2024 Dutasteride; tamsulosin hydrochloride Other Change notification 03.12.2024 Vinblastine sulfate Other Initial notification 03.12.2024 Epinephrine/adrenaline Production problem Initial notification 02.12.2024 Roxithromycin Production problem Change notification 02.12.2024 Rosuvastatin-Hemicalcium Other Change notification 02.12.2024 Rosuvastatin-Hemicalcium Other Change notification 02.12.2024 Rosuvastatin-Hemicalcium Other Change notification 02.12.2024 Lamotrigine Other Change notification 02.12.2024 Glucose monohydrate (Ph.Eur.) Other Initial notification 02.12.2024 Tamoxifen citrate Production problem Change notification 02.12.2024 Tamoxifen citrate Production problem Change notification 02.12.2024 Morphine sulphate (Ph.Eur.) Production problem Change notification 02.12.2024 Lamotrigine Other Change notification 02.12.2024 Acyclovir Production problem Change notification 02.12.2024 - 2024.12.02
Active ingredients Type of reason Message type Date of the last message Atomoxetine hydrochloride Production problem Change notification 29.11.2024 Phenoxymethylpenicillin benzathine Other Change notification 29.11.2024 Terazosin hydrochloride dihydrate Other Initial notification 29.11.2024 Ezetimibe Other Change notification 29.11.2024 Atomoxetine hydrochloride Production problem Change notification 29.11.2024 Levothyroxine sodium x H<2>O Other Change notification 29.11.2024 Liothyronine sodium Other Initial notification 29.11.2024 Acetylcholine chloride Production problem Change notification 29.11.2024 Anidulafungin Production problem Change notification 28.11.2024 Lenalidomide Other Change notification 28.11.2024 Clobetasol propionate (Ph.Eur.) Other Change notification 28.11.2024 Tacrolimus monohydrate Other Change notification 28.11.2024 Zoledronic acid monohydrate Production problem Initial notification 28.11.2024 Mesalazine Other Change notification 27.11.2024 Oxcarbazepine Other Change notification 27.11.2024 Pramipexole dihydrochloride monohydrate Other Initial notification 26.11.2024 Quetiapine fumarate (Ph.Eur.) Other Initial notification 26.11.2024 Doxycycline hyclate Other Change notification 26.11.2024 Amoxicillin trihydrate Other Change notification 26.11.2024 Methotrexate disodium Production problem Change notification 26.11.2024 Etoricoxib Other Change notification 25.11.2024 Levomepromazine hydrochloride Production problem Initial notification 25.11.2024 Cyclopentolate hydrochloride Production problem Initial notification 25.11.2024
フランス
- 2024.12.30
Status Update Ingredients Specialty Out of stock Dec. 24, 2024 pomalidomide Pomalidomide Viatris 1, 2, 3 and 4 mg, capsule – Supply tension Dec. 23, 2024 mivacurium chloride Mivacron 10 mg/5 ml and 20 mg/10 ml, solution for injection (IV) – - 2024.12.23
Status Update Availability Dec. 20, 2024 caffeine citrate Supply tension Dec. 20, 2024 ondansetron Supply tension Dec. 20, 2024 methylphenidate (hydrochloride) Supply tension Dec. 20, 2024 heparin calcium Supply tension Dec. 18, 2024 disulfiram Supply tension 18-Dec-24 gonadorelin (acetate) Remise à disposition Dec. 18, 2024 lenalidomide Availability Dec. 18, 2024 insulin lispro Supply tension Dec. 18, 2024 insulin aspart isophane biphasic (yeast/saccharomyces cerevisiae) - 2024.12.16
Status Update Specialty Out of stock 13-Dec-24 Ipratropium Teva 0.5 mg/2 ml adults, solution for inhalation by nebulizer in single-dose container – [ipratropium (bromide) Supply tension 13-Dec-24 Simulect 20 mg, powder and solvent for solution for injection or infusion – [basiliximab (mammal/mouse/Sp2/O) Supply tension 13-Dec-24 Mydriaticum 2 mg/0.4 ml, eye drops in single-dose container – [tropicamide] Out of stock 13-Dec-24 Etoposide Accord 20 mg/ml, dilutable solution for infusion – [etoposide] Supply tension Dec. 13, 2024 Lenalidomide Mylan 20 mg, capsule – [lenalidomide] Supply tension Dec. 13, 2024 Endoxan 50 mg, coated tablet – [cyclophosphamide] Out of stock 13-Dec-24 Vitamin B12 Delagrange 1000 micrograms/2 ml, solution for injection (IM) and oral use – [cyanocobalamine] Supply tension Dec. 12, 2024 Vitamin B12 Gerda 1000 µg/4 ml, solution for injection (IM) and oral use – [cyanocobalamine] Supply tension Dec. 12, 2024 Methylphenidate Arrow LP, sustained-release capsule – [methylphenidate (hydrochloride) Supply tension Dec. 12, 2024 Clarithromycin Viatris 25 mg/ml, granules for oral suspension and Zeclar 25 mg/ml, granules for oral suspension – [clarithromycin] Supply tension Dec. 12, 2024 Lasilix Retard 60 mg, capsule – [furosemide] Out of stock 10-Dec-24 Atracurium Pfizer 10 mg/mL, solution for injection/infusion (box of 5 ampoules of 50 mg/5 ml) – [atracurium]. Supply tension 10-Dec-24 Paliperidone Teva, prolonged-release suspension for injection – [paliperidone] Supply tension Dec. 10, 2024 Fucithalmic 1% ophthalmic gel – [fusidic acid] Availability Dec. 10, 2024 Tyenne 162 mg, solution for injection in prefilled pen and prefilled syringe – [tocilizumab] Supply tension Dec. 9, 2024 Risperidone L.P. 25 mg/2 mL; 37.5 mg/2 mL and 50 mg/2 mL, powder and solvent for prolonged-release suspension for injection in pre-filled syringe – [risperidone] Out of stock Dec. 9, 2024 Zophren 2 mg/ml, solution for injection in ampoule (IV) (box 1 ampoule of 4 ml) – [ondansetron] Supply tension Dec. 9, 2024 Rythmodan 250 mg extended-release, coated tablet – [disopyramide (phosphate)]. Out of stock Dec. 9, 2024 Clarithromycin Arrow 25 mg/ml, granules for oral suspension – [clarithromycin] Supply tension Dec. 9, 2024 Clarithromycin 50 mg/ml, granules for oral suspension – [clarithromycin] - 2024.12.09
Status Update Specialty Supply tension Dec. 6, 2024 Travoprost/Timolol 40 micrograms/mL + 5 mg/mL, eye drops solution – [timolol maleate, travoprost] Supply tension Dec. 6, 2024 Travoprost 40 micrograms/mL, eye drops solution – [travoprost] Supply tension 6-Dec-24 Exacyl 500 mg, film-coated tablet – (tranexamic acid) Supply tension Dec. 6, 2024 Cinacalcet 30 mg, 60 mg and 90 mg Film-coated tablet – [cinacalcet (hydrochloride) Supply tension 5-Dec-24 Clarithromycin 50 mg/ml, granules for oral suspension – [clarithromycin] Out of stock 5-Dec-24 Clarithromycin Arrow 25 mg/ml, granules for oral suspension – [clarithromycin] Out of stock 5-Dec-24 Clarithromycin Viatris 25 mg/ml, granules for oral suspension and Zeclar 25 mg/ml, granules for oral suspension – [clarithromycin] Supply tension 5-Dec-24 Amikacine Viatris 250 mg, 500 mg and 1g, powder for injectable solution in vial – [amikacine (sulfate d’) Supply tension Dec. 4, 2024 Specialties based on aprepitant 125 mg, 80 mg and 125 mg/80 mg capsules – [aprepitant] Supply tension 4-Dec-24 NovoMix 50 Flexpen 100 Units/ml, suspension for injection in pre-filled pen – [insulin aspart isophane biphasic (yeast/saccharomyces cerevisiae)] Supply voltage 4-Dec-24 Azactam 1 g, powder and solution for parenteral use – [aztreonam] Supply tension 4-Dec-24 Yellox 0.9 mg/ml, eye drops solution – [bromfenac sodium sesquihydrate]. Availability Dec. 3, 2024 Tcaps 62.5 micrograms, soft capsule – [levothyroxine] End of commercialization Dec. 3, 2024 Tsoludose, oral solution in unidose container – [levothyroxine] Supply tension 3-Dec-24 Praluent 75 mg, 150 mg and 300 mg, solution for injection in pre-filled pen – [alirocumab (mammalian/hamster/ cho cells) Supply tension Dec. 2, 2024 Tranxene 20 mg/2 ml, lyophilisate and solution for parenteral use – [clorazepate dipotassium]. Supply tension Dec. 2, 2024 Pegasys 90 micrograms, 135 micrograms and 180 micrograms solution for injection in pre-filled syringe – [peginterferon alfa-2a] - 2024.12.02
Status Update Specialty Supply tension Nov. 29, 2024 Atgam 50 mg/mL, solution for diluted infusion – [human T-lymphocyte immunoglobulin equine] [immunoglobulin equine anti-human T-lymphocyte]. Out of stock Nov. 29, 2024 Sodium lactate AP-HP 11.2% (w/v) solution for infusion – [sodium lactate] Availability Nov. 29, 2024 Befitine 100 mg/2 ml, solution for injection ampoule – [thiamine (hydrochloride)] Availability Nov. 29, 2024 Isocard, sublingual solution in spray bottle – [isosorbide dinitrate] Out of stock Nov. 28, 2024 Exacyl 500 mg, film-coated tablet – (tranexamic acid) Availability Nov. 28, 2024 Salbutamol 2.5mg/2.5ml and 5 mg/2.5 ml solution for inhalation by nebulizer in single-dose container – [salbutamol] Supply tension Nov. 28, 2024 Kenacort Retard 40 mg/1 ml, suspension for injection – [triamcinolone (acetonide of) Out of stock Nov. 28, 2024 Methotrexate Accord 100 mg/mL, dilutable solution for infusion (10 ml vial) – [methotrexate] Out of stock Nov. 28, 2024 Rifamycin Chibret 1000,000 IU per cent, eye drops solution – [rifamycin sodium]. Marketing discontinuation Nov. 28, 2024 Zoryon capsules and syrup – [methadone hydrochloride] Supply tension Nov. 27, 2024 Fluorescein Faure 0.5%, eye drops solution in single-dose container – [fluorescein sodium]. Availability Nov. 27, 2024 Bricanyl 0.5 mg/1 ml, solution for injection in ampoule – [terbutaline (sulfate de)] Supply tension Nov. 27, 2024 Cyanokit 5 g, powder for solution for infusion – [hydroxocobalamin] Supply voltage Nov. 26, 2024 Methylphenidate Viatris LP, sustained-release tablet – [Methylphenidate (hydrochloride)] [Methylphenidate (hydrochloride) Supply tension Nov. 26, 2024 Caffeine citrate Cooper 25 mg/mL, solution for injection and drinking – [caffeine citrate]. Marketing discontinuation Nov. 26, 2024 Tsoludose, solution buvable en récipient unidose – [levothyroxine]. Supply tension Nov. 26, 2024 Methylphenidate Biogaran LP, extended-release tablet – [methylphenidate (hydrochloride) Remise à disposition Nov. 26, 2024 Ritalin LP 40 mg, extended-release capsule – [methylphenidate (hydrochloride)] Availability Nov. 26, 2024 Potassium citrate AP-HP 1 g, sachet of 100 capsules – [potassium citrate]
英国
- 2024.12.19
医薬品供給通知:Insulatard®(イソファンインスリン、ヒト)Penfill® 100units/ml懸濁液、注射用3mlカートリッジ
これらは廃止されています。在庫は2025年6月までに枯渇する見込みです。Humulin® I KwikPen®(イソファンインスリン、ヒト)注射用100ユニット/ ml懸濁液3mlプレフィルドペンが利用可能で、2025年4月からの需要増加を完全にサポートできます。
出典:Community Pharmacy England
セファレキシン経口懸濁液無糖用に発行された2つのSSP
供給の中断により、12月10日から、これら2つのプロトコルは、セファレキシン無糖経口懸濁液125mg / 5ml(SSP077)および250mg / 5ml(SSP078)の処方に対して、無糖供給が許可されることを規定しています。SSPは現在、2025年1月31日(金)に有効期限が切れます。
出典:Community Pharmacy England
- 2024.12.03
Medicine supply notification: Imiquimod (Aldara® 5% and Bascellex® 50mg/g) cream 250mg sachets
医薬品供給通知:イミキモド(アルダラ® 5%、バセレックス® 50mg/g)クリーム250mg小袋
イミキモド5%クリーム250mg小袋(アルダラ®&バセレックス®)とポドフィロトキシン0.15%クリーム(ワーティコン®)は、2025年1月中旬から下旬まで在庫切れです。フルオロウラシル5%クリームが利用可能ですが、需要の増加をサポートすることはできません。代替品が利用可能であり、ライセンスのない供給品が調達される場合があります。
出典:Community Pharmacy EnglandMedicine supply notification: Diclofenac (Voltarol® Ophtha Multidose) 0.1% eye drops
医薬品供給通知:ジクロフェナク(ボルタロール®オフサマルチドーズ)0.1%点眼薬
こちらの目薬は2025年3月中旬まで在庫切れです。0.1%の防腐剤フリー(PF)点眼薬は引き続き入手可能ですが、PF点眼薬が必要な人のために予約する必要があります。ケトロラック0.5%点眼薬は在庫が残っており、需要の増加に対応できます。
出典:Community Pharmacy England
EU
EUの情報はありません。